A company holds an equity investment classified as AFS. At the beginning of 2017, this investment is reported at a value of $4,000,000. Gains of $500,000 have been previously reported, and no impairment losses have been reported. At the end of 2017, the market value of the investment is $2,000,000, and it is determined that the decline in value qualifies for treatment as an impairment loss.

How is this information reported on the companys 2017 income statement and statement of comprehensive income?